Fosun picks two for $800m Gland Pharma acquisition loan

By Shruti Chaturvedi
29 Jul 2016

Shanghai Fosun Pharmaceutical Group has roped in two lenders for an $800m financing to support its acquisition of Indian firm Gland Pharma.

Australia and New Zealand Bank and Standard Chartered will supply a one year loan of up to $800m to back the purchase, said a source close to the matter.

Fosun Pharma will pay up to $1.26bn for an 86% stake in the target. The transaction will see private equity ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial